Rigel Pharmaceuticals Inc (RIGL)
1.13
-0.03
(-2.59%)
USD |
NASDAQ |
Apr 16, 16:00
1.13
0.00 (0.00%)
After-Hours: 18:03
Rigel Pharmaceuticals Debt to Equity Ratio: -2.081 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.081 |
| September 30, 2023 | -1.874 |
| June 30, 2023 | -2.119 |
| March 31, 2023 | -2.452 |
| December 31, 2022 | -2.897 |
| September 30, 2022 | -1.990 |
| June 30, 2022 | -8.114 |
| March 31, 2022 | 4.391 |
| December 31, 2021 | 0.6556 |
| September 30, 2021 | 0.4004 |
| June 30, 2021 | 0.2916 |
| March 31, 2021 | 0.2534 |
| December 31, 2020 | 0.5823 |
| September 30, 2020 | 0.3893 |
| June 30, 2020 | 0.3135 |
| March 31, 2020 | 0.1252 |
| December 31, 2019 | 0.1823 |
| September 30, 2019 | 0.1421 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-8.114
Minimum
Jun 2022
4.391
Maximum
Mar 2022
-0.7264
Average
0.1421
Median
Sep 2019
Debt to Equity Ratio Benchmarks
| Nektar Therapeutics | 0.00 |
| Avid Bioservices Inc | 0.7685 |
| Stereotaxis Inc | 0.00 |
| Cara Therapeutics Inc | 0.00 |
| Blueprint Medicines Corp | 1.828 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 117.22M |
| Total Liabilities (Quarterly) | 145.87M |
| Shareholders Equity (Quarterly) | -28.64M |
| Current Ratio | 1.864 |
| Net Debt Paydown Yield | -1.59% |